Ascendis Pharma AS Stock Predictions

The Future of Housing Is Being Built Now

Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.

Sell

ASND
Ascendis Pharma AS

Last Price:

$159.86

Seasonality Move:

8.98%

7 Day Trial

ALL ACCESS PASS

$ 7

Pacaso, now reserving Nasdaq ticker PCSO, is offering shares at $2.80 until May 29.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.*Pacaso recently received their ticker reservation with Nasdaq

Ascendis Pharma AS Stock Forecast

Over the next 52 weeks, Ascendis Pharma AS has on average historically risen by 37.3% based on the past 10 years of stock performance.
Ascendis Pharma AS has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%
Is Ascendis Pharma AS Stock Undervalued?

The current Ascendis Pharma AS [ASND] share price is $159.24. The Score for ASND is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
ASND is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Ascendis Pharma AS Stock Go Up Next Year?

Over the next 52 weeks, Ascendis Pharma AS has on average historically risen by 37.3% based on the past 10 years of stock performance.

Ascendis Pharma AS Stock Rating

Sell

Ascendis Pharma AS (ASND) is a Sell

Is Ascendis Pharma AS overpriced?

Ascendis Pharma AS has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%

Ascendis Pharma AS Stock Price History

Is ASND stock going to rise?

The current trend is relatively stagnant and ASND is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

Denmark

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

ascendispharma.com

52-Week Data

52-Week High:

183.00

52-Week Low:

111.09

Prediction Charts

Market Cap:

9.6B

Price in USD:

159.24

Volume:

384.9K

Beta:

0.61

Technical Analysis

SMA50:

158.22

SMA100:

148.52

SMA200:

140.64

52-Wk Change:

25.06%

Stock Predictions

Is Ascendis Pharma AS stock public?

Yes, Ascendis Pharma AS is a publicly traded company.
What is the Ascendis Pharma AS stock quote today?

The Ascendis Pharma AS stock price is 159.24 USD today.
How to buy Ascendis Pharma AS stock online?

You can buy Ascendis Pharma AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
May-8	161.10	159.39	162.71	156.02
May-9	159.45	151.25	161.39	151.11
May-12	153.41	154.43	158.33	152.45
May-13	155.20	161.52	162.30	154.64
May-14	161.78	157.20	165.26	156.28
May-15	157.14	157.54	159.03	150.89
May-16	155.01	157.60	160.56	154.80
May-19	157.00	160.33	160.38	156.46
May-20	160.34	161.57	162.22	157.70
May-21	160.38	158.10	162.38	157.02
May-22	157.97	160.05	161.79	156.10
May-23	157.77	162.00	162.12	153.49
May-27	163.55	157.27	163.55	156.83
May-28	156.71	159.24	160.30	156.56

Ascendis Pharma AS Earnings

Ascendis Pharma AS Earnings Report: Per Share Ascendis Pharma AS Earnings Q1 Q2 Q3 and Q4 last year and next year.

Ascendis Pharma AS Forecast Revenue Growth

Ascendis Pharma AS Stock Analysis: Historical quarterly revenues per share for Ascendis Pharma AS and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.59 per share, an increase this year of $2.02 per share, and an increase next year of $7.29 per share.

* Ascendis Pharma AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.